Cyntellect, Inc.

Daiichi enters funded-research agreement

Published in Medical Imaging Business Week, April 28th, 2005

Cyntellect, Inc., a privately held biotechnology company, announced the company has entered into a research agreement with Daiichi Pharmaceutical Co., Ltd., to utilize Cyntellect's high-throughput cell imaging and laser-based cell manipulation technology, LEAP, for novel drug discovery.

Under the terms of the collaboration, Cyntellect will design, configure, and run LEAP cell-based assays against a compound collection provided by Daiichi. Specific financial terms were not disclosed.

Dr. Fred Koller, president and CTO, said, "Daiichi's commitment to Cyntellect and LEAP represents another important validation of our technology and highlights the unique...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Imaging Business Week

Source: Medical Imaging Business Week (2005-04-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry